| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
6 companies
Jean Jacques Bienaime is Director at BMRN and has filed Form 4s across 6 companies. From September 2015 to August 2026, the filings on record show 21 open-market purchases and 123 sales. Jean Jacques Bienaime's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $31.2M at current prices.
Historically, Jean Jacques Bienaime's trades have earned a middling insider score of 68/100 across 67 rated trades. Over a 12-month horizon, 64.3% of those trades were profitable, with an average 12-month return of +8.5%.
The biggest single holding is BMRN (~$26.4M) as Director. The BMRN filings lean toward selling, a net 2,115,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 7,000 | $83.58 | $585,060.00 | -2.3% | |
| Feb 18, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 7,000 | $85.08 | $595,560.00 | -2.3% | |
| Feb 17, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 8,000 | $84.54 | $676,320.00 | -2.6% | |
| Jan 29, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 16,667 | $82.79 | $1,379,860.81 | -5.3% | |
| Jan 27, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 8,333 | $85.49 | $712,388.17 | -2.7% | |
| Dec 29, 2020 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sell | 3,000 | $88.48 | $265,425.00 | -1.0% | |
| Nov 10, 2020 | INCY Incyte Corp | Director | Sell | 798 | $83.00 | $66,234.00 | -8.4% | |
| May 8, 2020 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 20,000 | $91.72 | $1,834,400.00 | -6.3% | |
| May 4, 2020 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 9,000 | $88.61 | $797,520.00 | -2.9% | |
| Apr 28, 2020 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 40,000 | $97.66 | $3,906,200.00 | -11.8% |